However, when IL-22-producing Th17, NKT, and Th22 cells infiltrate into the tumor, the increased amount of IL-22 can possibly offset the effect of BTN2A1 and Vγ9Vδ2 T cells, which eventually leads to tumor progression [39,49,50]. The gene discussed is BTN2A1; the disease is neoplasm.